Vertex Pharmaceuticals, Inc’s filing revealed that its Officer Biller Jonathan acquired Company’s shares for reported $1.58 million on Feb 11 ’25. In the deal valued at $459.87 per share,3,433 shares were bought.
Then, Tatsis Ourania bought 310 shares, generating $142,547 in total proceeds.
Before that, Atkinson Edward Morrow III bought 1,747 shares. Vertex Pharmaceuticals, Inc shares valued at $803,323 were divested by the Officer at a price of $459.83 per share.
Canaccord Genuity upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Hold from a a Sell in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who decreased its forecast for the stock in late January from “an Overweight” to “an Equal weight”. H.C. Wainwright also remained covering VRTX and reiterated its “Buy” recommendation on December 20, 2024. Oppenheimer revised its rating on December 19, 2024. It rated VRTX as “a Perform” which previously was an “an Outperform”.
Price Performance Review of VRTX
On Tuesday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock fall -3.14% to $455.22. Over the last five days, the stock has lost -5.61%. Vertex Pharmaceuticals, Inc shares have risen nearly 13.04% since the year began. Nevertheless, the stocks have risen 7.60% over the past one year. While a 52-week high of $519.88 was reached on 02/05/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $440.12, while 200 days put it at $461.68.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 449.08, which if violated will result in even more drops to 442.93. On the upside, there is a resistance level at 464.78. A further resistance level may holdings at 474.33. The Relative Strength Index (RSI) on the 14-day chart is 53.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 6.10, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 54.39%. Stochastics %K at 60.08% indicates the stock is a holding.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2025-01-15, growing by 0.88 million shares to a total of 4.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 3.51 million shares. There was a rise of 20.07%, which implies that there is a positive sentiment for the stock.
